Gastrointestinal drugs are medications used to treat disorders of the stomach and intestines, such as ulcers, indigestion, heartburn, and irritable bowel syndrome. While these medications can be effective in relieving symptoms, they can also be toxic if taken in large doses or in combination with other drugs. The primary side effect of gastrointestinal drugs is nausea and vomiting, which can be severe enough to require hospitalization. In addition, they can cause dehydration, electrolyte imbalances, and organ damage. Long-term use of gastrointestinal drugs can lead to liver and kidney damage. The most dangerous type of gastrointestinal drugs is those that contain anti-inflammatory agents, such as corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs). These medications can cause serious gastrointestinal side effects, including ulcers, bleeding, and perforation of the stomach or intestines. NSAIDs also increase the risk of heart attack and stroke. Other gastrointestinal drugs that can be toxic include antacids, proton pump inhibitors, and H2 blockers. Antacids can cause diarrhea, constipation, and abdominal pain. Proton pump inhibitors, which are used to reduce stomach acid, can cause kidney damage and bone fractures. H2 blockers, which are used to reduce stomach acid, can cause anemia and low levels of potassium, magnesium, and calcium in the blood. In addition to these potential side effects, gastrointestinal drugs can also interact with other medications. For example, they can reduce the effectiveness of antibiotics and anticoagulants. Therefore, it is important to tell your doctor about all the medications you are taking before starting a gastrointestinal medication. In conclusion, gastrointestinal drugs can be helpful in treating certain gastrointestinal disorders, but they can also be toxic if taken in large doses or in combination with other drugs. Before taking any gastrointestinal medication, be sure to discuss the potential risks and side effects with your doctor.
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China